EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹172 Cr | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹172 Cr |
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹132 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹310 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹172 Cr | 38.68 | |
| Mar2025 | ₹124 Cr | -6.26 | |
| Mar2024 | ₹132 Cr | -67.20 | |
| Mar2023 | ₹404 Cr | 30.25 | |
| Mar2022 | ₹310 Cr | - | |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹38,238.8 Cr | 2% | 6.4% | 41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2% |
6.4% |
41.7% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses